避孕套市场－全球产业规模、份额、趋势、机会及预测（依性别、类型、通路、地区及竞争格局划分，2021-2031年）

全球避孕套市场预计将从 2025 年的 122.2 亿美元成长到 2031 年的 203.1 亿美元，年复合成长率为 8.84%。

保险套是一种鞘状屏障装置，通常由乳胶或聚氨酯製成，用于性交过程中以降低意外怀孕的风险并预防感染疾病的传播。市场的主要驱动因素包括性行为感染传染病发生率的上升和政府严格的计划生育政策。这些因素构成了对价格合理的预防解决方案的持续结构性需求，这种需求不受暂时性消费趋势的影响，从而确保了全球医疗保健系统对疾病预防产品的基本需求。

然而，国际资金和采购的减少给避孕套市场带来了巨大挑战，阻碍了其在关键地区的广泛应用。根据联合国爱滋病规划署（UNAIDS）的数据，到2025年，全球公共部门的保险套采购量预计将比2011年的尖峰时段平均下降30%。补贴供应的减少对市场成长构成重大障碍，尤其是在开发中国家。

市场驱动因素

全球性行为感染感染（STI）和爱滋病毒（HIV）疫情的日益蔓延是推动保险套市场发展的主要动力，因此需要持续稳定的生产量以满足公共卫生需求。不断上升的感染率促使卫生组织将屏障避孕器作为第一道防线，确保市场规模不受商业週期波动的影响。根据全球抗爱滋病、结核病和疟疾基金于2025年9月发布的《2025年绩效报告》，2024年全球将新增130万例爱滋病毒感染病例，凸显了持续获得预防措施的重要性。即使在已开发国家，这趋势也十分明显。根据HIV.gov的数据，2025年的初步监测数据显示，2024年美国将新增超过220万例披衣菌感染、淋病和梅毒病例，这强调了广泛提供预防性药物以遏制这些传播途径的必要性。

政府主导的计划生育和疾病预防计画是第二个关键驱动因素，透过大规模的机构采购计画来稳定需求。各国卫生署和国际组织积极补贴并向高风险族群分发预防性药物，并为生产者建立稳定的供应管道，以抵销私人零售部门的波动。这些计画力度尤其大，政府干预促使疾病负担重的地区大规模消耗药品。例如，根据乌干达爱滋病委员会2025年12月发布的报告《乌干达实现97%的爱滋病毒抑制率》，公部门在2024年分发了约2.079亿个男用保险套。这些广泛的公共部门努力确保了核心产业的生产能够继续满足这些规定的供应链需求，即使资金筹措状况改变。

市场挑战

国际资金筹措和采购量的下降对全球避孕套市场的扩张构成重大障碍。资金紧缩直接影响发展中地区的保险套供应，这些地区的市场成长严重依赖国际卫生组织的补贴性批量采购。当捐助资金停滞或减少时，供应链就会中断，导致高需求地区出现库存短缺，这些地区转向商业零售在经济上不可行。因此，製造商面临订单量不稳定的问题，扰乱生产计画，降低收入稳定性。

这种对外部援助的依赖造成了脆弱的市场生态系统，极易出现预算短缺。无法获得稳定的资金筹措限制了预防项目的覆盖范围，并有效地阻碍了市场规模的成长。据全球基金称，国际资金的减少对疾病预防工作的进展构成了严重威胁，并导致2024年全球新增130万例爱滋病毒感染病例。这种关联性凸显了资金短缺如何直接导致产品供应减少和市场停滞，从而阻碍了新兴经济体中该产业充分发挥其潜力。

市场趋势

各种增强愉悦感的质地和配方层出不穷，从根本上重塑了市场格局，将消费者的焦点从基本的预防转向性健康和体验满足。製造商正在开发具有刺激性纹理、凸点和润滑剂的产品，以增强性快感，旨在吸引与价格敏感的公共部门截然不同的高端客户群。这种策略透过将保险套作为生活方式产品而非医疗必需品进行行销，有效地使品牌免受大宗商品价格压力的影响。根据利洁时集团于2025年10月发布的“2025年第三季业绩报告”，新兴市场的“私密健康”品类正经历两位数的增长，这主要得益于Benzocaine因避孕套等新型高性能创新产品的快速普及。

同时，市场正明显转向直接面向消费者（DTC）和订阅零售模式，以避免国际捐助资金带来的波动性。儘管机构采购面临预算限制，但私人零售领域正在扩张，品牌透过电子商务和实体店伙伴关係与消费者建立直接联繫，并强调品牌忠诚度和供应稳定性。这种商业性韧性抵消了政府采购的下降，并透过持续的私人购买确保了收入稳定。根据Church & Dwight公司2025年10月发布的2025年第三季财报，该公司国内有机销售额成长了2.3%。这项业绩主要得益于其高端Trojan避孕套系列产品零售需求的持续成长。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球保险套市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 性别（男，女）
  • 依类型（乳胶保险套、非乳胶保险套）
  • 按分销管道（超级市场/大卖场、药局/药局、便利商店、线上、其他（百货公司等））
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美保险套市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

第七章 欧洲保险套市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章 亚太地区保险套市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲避孕套市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美保险套市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球保险套市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Okamoto Industries, Inc.
• Cupid Limited
• Reckitt Benckiser Group
• Karex Berhad
• Church & Dwight Co., Inc.
• Fuji Latex Co., Ltd.
• Leloi AB
• LifeStyles Healthcare Pte Ltd.
• Veru, Inc.
• Mayer Laboratories, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Condom Market is projected to expand from USD 12.22 Billion in 2025 to USD 20.31 Billion by 2031, reflecting an 8.84% CAGR. A condom is defined as a sheath-shaped barrier device, usually made of latex or polyurethane, used during sexual intercourse to decrease the likelihood of unintended pregnancy and prevent infection transmission. The market is chiefly sustained by core drivers such as the rising incidence of sexually transmitted diseases and strict government family planning initiatives. These factors establish a lasting structural demand for affordable prophylactic solutions that operates independently of temporary consumer trends, ensuring a fundamental need for disease prevention products within international healthcare systems.

However, the industry confronts a major challenge concerning the decrease in international funding and procurement, which obstructs broad distribution in key regions. Data from the Joint United Nations Programme on HIV/AIDS reveals that in 2025, estimated global public sector condom procurement dropped by an average of 30 percent from the peaks seen in 2011. This contraction in subsidized availability acts as a significant barrier to market volume growth, particularly in developing economies that rely heavily on donor-funded sexual health programs for a steady supply.

Market Driver

The growing global prevalence of sexually transmitted infections (STIs) and HIV acts as a primary catalyst for the condom market, requiring consistent manufacturing output to satisfy public health needs. As infection rates rise, health agencies prioritize barrier methods as a first line of defense, securing steady market volume irrespective of commercial cycles. According to the 'Results Report 2025' by The Global Fund to Fight AIDS, Tuberculosis and Malaria published in September 2025, 1.3 million new HIV infections were recorded globally in 2024, highlighting the crucial need for continued prophylactic access. This trend is also evident in developed nations; HIV.gov reported that provisional surveillance data in 2025 showed over 2.2 million cases of chlamydia, gonorrhea, and syphilis in the United States in 2024, reinforcing the structural necessity to curb these transmission vectors through widespread availability.

Government-led initiatives for family planning and disease prevention serve as a second major driver, stabilizing demand through extensive institutional procurement programs. National health departments and international bodies actively subsidize or freely distribute prophylactics to high-risk groups, creating a reliable volume channel for manufacturers that balances volatility in the private retail sector. These programs are particularly aggressive in regions with high disease burdens, where state intervention results in massive unit consumption. For instance, the Uganda AIDS Commission's 'Uganda Scores 97% HIV Suppression' report from December 2025 noted that public sector distribution of male condoms rose to approximately 207.9 million units in 2024. Such broad public sector commitments ensure that despite funding changes, core industrial output remains engaged to fulfill these mandated supply chains.

Market Challenge

The decline in international funding and procurement poses a critical barrier to the expansion of the Global Condom Market. This financial contraction directly affects the volume of products distributed in developing regions, where market growth depends heavily on subsidized bulk purchasing by global health entities. When donor contributions stagnate or fall, the supply chain fractures, causing immediate stock shortages in high-demand areas that lack the economic ability to shift to commercial retail purchasing. Consequently, manufacturers face unpredictable order volumes, which disrupts production planning and undermines revenue stability.

This reliance on external aid creates a fragile market ecosystem prone to budgetary deficits. The failure to secure consistent financing limits the reach of prevention programs, effectively capping market volume. According to the Global Fund, in 2024, decreasing international funding presented a serious threat to disease prevention progress, contributing to a scenario where 1.3 million new HIV infections were recorded globally. This correlation highlights how funding gaps directly lead to reduced product accessibility and market stagnation, preventing the industry from realizing its full potential in emerging economies.

Market Trends

The diversification of pleasure-enhancing textures and formulations is fundamentally reshaping the market by shifting consumer focus from basic prophylactic utility to sexual wellness and experiential satisfaction. Manufacturers are increasingly engineering products with stimulating ribs, dots, and desensitizing lubricants to attract a premium clientele that operates outside the price-sensitive public sector. This strategy effectively insulates brands from commodity pricing pressures by marketing condoms as lifestyle products rather than medical necessities. According to Reckitt Benckiser Group plc's 'Q3 2025 Trading Update' from October 2025, the company recorded double-digit growth in its Intimate Wellness category within emerging markets, specifically driven by the rapid uptake of new performance-focused innovations such as Benzocaine-infused condoms.

Simultaneously, there is a distinct shift toward direct-to-consumer and subscription-based retail models which circumvents the volatility associated with international donor funding. While institutional procurement faces budgetary constraints, the private retail segment is expanding as brands establish direct relationships with users through e-commerce and physical retail partnerships that emphasize brand loyalty and consistent availability. This commercial robustness provides a counterweight to the declining government tender volumes, ensuring revenue stability through recurring private purchases. According to Church & Dwight Co., Inc.'s 'Q3 2025 Earnings Press Release' from October 2025, the company's domestic organic sales grew by 2.3 percent, a performance primarily led by the sustained retail demand for its premium Trojan condom portfolio.

Key Market Players

• Okamoto Industries, Inc.
• Cupid Limited
• Reckitt Benckiser Group
• Karex Berhad
• Church & Dwight Co., Inc.
• Fuji Latex Co., Ltd.
• Leloi AB
• LifeStyles Healthcare Pte Ltd.
• Veru, Inc.
• Mayer Laboratories, Inc.

Report Scope

In this report, the Global Condom Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Condom Market, By Gender

• Male
• Female

Condom Market, By Type

• Latex Condom
• Non-Latex Condom

Condom Market, By Distribution Channel

• Supermarkets/Hypermarkets
• Drug/Pharmacy Stores
• Convenience Stores
• Online
• Others (Departmental Stores, etc.)

Condom Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Condom Market.

Available Customizations:

Global Condom Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Condom Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Gender (Male, Female)
  • 5.2.2. By Type (Latex Condom, Non-Latex Condom)
  • 5.2.3. By Distribution Channel (Supermarkets/Hypermarkets, Drug/Pharmacy Stores, Convenience Stores, Online, Others (Departmental Stores, etc.))
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Condom Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Gender
  • 6.2.2. By Type
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Condom Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Gender
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Condom Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Gender
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Condom Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Gender
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Distribution Channel

7. Europe Condom Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Gender
  • 7.2.2. By Type
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Condom Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Gender
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. France Condom Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Gender
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. United Kingdom Condom Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Gender
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Condom Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Gender
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Condom Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Gender
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Condom Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Gender
  • 8.2.2. By Type
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Condom Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Gender
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Condom Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Gender
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Condom Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Gender
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Condom Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Gender
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Condom Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Gender
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Condom Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Gender
  • 9.2.2. By Type
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Condom Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Gender
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. UAE Condom Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Gender
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. South Africa Condom Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Gender
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Distribution Channel

10. South America Condom Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Gender
  • 10.2.2. By Type
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Condom Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Gender
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Colombia Condom Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Gender
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. Argentina Condom Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Gender
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Condom Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Okamoto Industries, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Cupid Limited
• 15.3. Reckitt Benckiser Group
• 15.4. Karex Berhad
• 15.5. Church & Dwight Co., Inc.
• 15.6. Fuji Latex Co., Ltd.
• 15.7. Leloi AB
• 15.8. LifeStyles Healthcare Pte Ltd.
• 15.9. Veru, Inc.
• 15.10. Mayer Laboratories, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer